Evidence map›Paper›PMID 26668310›Full record

ArticleThe Journal of biological chemistry2016

Identification of an Endogenously Generated Cryptic Collagen Epitope (XL313) That May Selectively Regulate Angiogenesis by an Integrin Yes-associated Protein (YAP) Mechano-transduction Pathway.

Jacquelyn J Ames, Liangru Contois, Jennifer M Caron, Eric Tweedie, Xuehui Yang, Robert Friesel, Calvin Vary, Peter C Brooks

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Current progress in the inflammatory background of angiogenesis in gynecological cancers.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jacquelyn J AmesFrom the Maine Medical Center Research Institute, Center for Molecular Medicine, Scarborough, Maine 04074.
Liangru ContoisFrom the Maine Medical Center Research Institute, Center for Molecular Medicine, Scarborough, Maine 04074.
Jennifer M CaronFrom the Maine Medical Center Research Institute, Center for Molecular Medicine, Scarborough, Maine 04074.
Eric TweedieFrom the Maine Medical Center Research Institute, Center for Molecular Medicine, Scarborough, Maine 04074.
Xuehui YangFrom the Maine Medical Center Research Institute, Center for Molecular Medicine, Scarborough, Maine 04074.
Robert FrieselFrom the Maine Medical Center Research Institute, Center for Molecular Medicine, Scarborough, Maine 04074.
Calvin VaryFrom the Maine Medical Center Research Institute, Center for Molecular Medicine, Scarborough, Maine 04074.
Peter C BrooksFrom the Maine Medical Center Research Institute, Center for Molecular Medicine, Scarborough, Maine 04074 brookp1@mmc.org.
Maine Medical Center Research Institute · US

Funding

Transcriptional Decisions in Endothelial Cell DifferentiationP20RR015555 · NCRR · MAINE MEDICAL CENTER · PI PRUDOVSKY, IGOR · 2000 to 2009
$21.4M
Progenitor Cell Analysis CoreP30GM106391 · NIGMS · MAINEHEALTH · PI WOJCHOWSKI, DON MICHAEL · 2013 to 2017
$5.7M
Phase III COBRE in Vascular BiologyP30GM103392 · NIGMS · MAINEHEALTH · PI ST. GERMAIN, DONALD L. · 2012 to 2016
$4.7M
CRYPTIC DOMAINS OF COLLAGEN IV IN TUMOR GROWTHR01CA091645 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BROOKS, PETER C. · 2000 to 2011
$3.3M
Regulation of TGF-beta Receptor-dependent Vascular DiseaseR01HL083151 · NHLBI · MAINEHEALTH · PI VARY, CALVIN PARDEE HULL · 2007 to 2011
$2.0M
Regulation of Endothelial Cell Function by SproutyR01HL065301 · NHLBI · MAINE MEDICAL CENTER · PI FRIESEL, ROBERT E · 2001 to 2010
$2.0M
NCI NIH HHS CA91645NCI NIH HHS R01 CA091645NCRR NIH HHS P20 RR015555NCRR NIH HHS P20RR15555NCRR NIH HHS P20 RR181789NHLBI NIH HHS HL083151NHLBI NIH HHS HL65301NHLBI NIH HHS R01 HL065301NHLBI NIH HHS R01 HL083151NIGMS NIH HHS 5P30GM103392NIGMS NIH HHS P30 GM103392NIGMS NIH HHS P30 GM106391
6 · The paper itself

Abstract

Extracellular matrix (ECM) remodeling regulates angiogenesis. However, the precise mechanisms by which structural changes in ECM proteins contribute to angiogenesis are not fully understood. Integrins are molecules with the ability to detect compositional and structural changes within the ECM and integrate this information into a network of signaling circuits that coordinate context-dependent cell behavior. The role of integrin αvβ3 in angiogenesis is complex, as evidence exists for both positive and negative functions. The precise downstream signaling events initiated by αvβ3 may depend on the molecular characteristics of its ligands. Here, we identified an RGD-containing cryptic collagen epitope that is generated in vivo. Surprisingly, rather than inhibiting αvβ3 signaling, this collagen epitope promoted αvβ3 activation and stimulated angiogenesis and inflammation. An antibody directed to this RGDKGE epitope but not other RGD collagen epitopes inhibited angiogenesis and inflammation in vivo. The selective ability of this RGD epitope to promote angiogenesis and inflammation depends in part on its flanking KGE motif. Interestingly, a subset of macrophages may represent a physiologically relevant source of this collagen epitope. Here, we define an endothelial cell mechano-signaling pathway in which a cryptic collagen epitope activates αvβ3 leading to an Src and p38 MAPK-dependent cascade that leads to nuclear accumulation of Yes-associated protein (YAP) and stimulation of endothelial cell growth. Collectively, our findings not only provide evidence for a novel mechano-signaling pathway, but also define a possible therapeutic strategy to control αvβ3 signaling by targeting a pro-angiogenic and inflammatory ligand of αvβ3 rather than the receptor itself.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCell Cycle ProteinsCell Line, TumorCollagenEndothelial CellsEpitopesHumansIntegrin alphaVbeta3MAP Kinase Signaling SystemMechanotransduction, CellularMiceNeovascularization, Physiologicp38 Mitogen-Activated Protein KinasesPhosphoproteinssrc-Family KinasesAdaptor Proteins, Signal TransducingCell Cycle ProteinsCollagenEpitopesIntegrin alphaVbeta3p38 Mitogen-Activated Protein KinasesPhosphoproteinssrc-Family KinasesTranscription FactorsYAP1 protein, humanYap1 protein, mouseYAP-Signaling Proteinsangiogenesiscollagenextracellular matrixinflammationintegrinp38 MAPKYes-associated protein (YAP)

Identifiers

PMID26668310
PMCPMC4742740
OpenAlexW2414422246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.